DPx Holdings CEO, Jim Mullen, Keynote Dinner Speaker at PharmaLink 2014
Jim Mullen, CEO of DPx Holdings Incorporated , will be the keynote dinner speaker at PharmaLink 2014, March 18-21 at Xavier University in Cincinnati, Ohio. DPx is the privately held parent company of the Patheon, DSM Fine Chemicals and Banner Life Sciences businesses. The company is a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.
Mullen’s presentation will take place on March 20 at 5:45 p.m. during the dinner reception held in the Riverfront Club at the Great American Ball Park, the home of the Cincinnati Reds. In Mullen’s presentation, “Leadership in a Complex Global Supply Chain,” he will share his thoughts on how all players in the complex global supply chain have a vital and interdependent leadership role in ensuring medicines are safe and effective for patients around the world.
“I am honored to have been selected as the keynote dinner speaker for this year’s conference,” says Jim Mullen, CEO, DPx. “I look forward to sharing my thoughts on what it takes for a supply chain to produce safe and effective medicines.”
Mullen will also be a panel member for two sessions on Thursday, March 20. The first titled “Operationalizing Effective Integrated Supply Chains” at 2:15 p.m., will teach attendees how to implement a paradigm shifting model that works to establish an effective low risk supply chain that delivers high-quality products. The second panel, “How to Influence Meaningful Change,” at 3:45 p.m., will discuss how employees can effectively have their voices heard within their organization. Attendees will learn tools that will help them communicate business needs and ideas effectively.
For more information on the PharmaLink conference, visit http://xavierhealth.org/pharmaceutical-industry/pharmalink .
Tel: (919) 226-3200
DPx is the privately held parent company of the Patheon, Banner Life Sciences, and DSM Fine Chemicals businesses. The company is a leading provider of CDMO services, pharmaceutical products and products for other industries. Founded in 2014 as a result of a deal between JLL Partners and Royal DSM, DPx has three core business units, comprised of Patheon Pharma Services, DSM Fine Chemicals and Banner Life Sciences. With global headquarters in Durham, N.C., DPx has a footprint of 24 locations across North America, Europe, Latin America and Australia with more than 8,000 employees. DPx offers customers unsurpassed quality, integrated offerings and value through these three core business units. For more information visit www.patheon.com/DPx .
Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Patheon, a DPx business unit, encompasses the combined CMO capabilities and pharmaceutical product development services (PDS), as well as the Biosolutions and Biologics (BIO) business. For more information visit http://www.patheon.com .
About DSM Fine Chemicals
Announced in March 2014 as a business unit under the DPx umbrella, DSM Fine Chemicals provides active pharmaceutical ingredients (API) as well as ES/IM products and services that are primarily comprised of agricultural and crop protection chemicals. Its main focus is custom synthesis aimed at pharma and fine chemicals markets, of which the agro-chemicals sector is a primary focus. ES/IM also produces maleic anhydride and derivatives.
About Banner Life Sciences
Banner Life Sciences’ mission is to advance human health with innovation and creativity generating value for society and investors. Acquired by Patheon in December 2012, Banner Life Sciences is DPx’s proprietary products business. For more information visit http://www.bannerls.com .